Literature DB >> 33376278

Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90.

Abhishek Pandey1, Swarnendu Mandal1, Manoj K Das1, Prasant Nayak1.   

Abstract

Entities:  

Year:  2020        PMID： 33376278      PMCID： PMC7759172          DOI： 10.4103/iju.IJU_389_20

Source DB:  PubMed          Journal:  Indian J Urol        ISSN： 0970-1591


× No keyword cloud information.
  2 in total

1.  Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillance.

Authors:  Mufaddal M Mamawala; Karthik Rao; Patricia Landis; Jonathan I Epstein; Bruce J Trock; Jeffrey J Tosoian; Kenneth J Pienta; H Ballentine Carter
Journal:  BJU Int       Date:  2016-08-29       Impact factor: 5.588

2.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.

Authors:  Hashim U Ahmed; Ahmed El-Shater Bosaily; Louise C Brown; Rhian Gabe; Richard Kaplan; Mahesh K Parmar; Yolanda Collaco-Moraes; Katie Ward; Richard G Hindley; Alex Freeman; Alex P Kirkham; Robert Oldroyd; Chris Parker; Mark Emberton
Journal:  Lancet       Date:  2017-01-20       Impact factor: 79.321
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.